Deep Dive Oncology special: reflections on ASCO

COVER-Oncology

Cover

Deep Dive Oncology special: reflections on ASCO (2018)

Click here

Introduction

Welcome from the Editor

Click here

CAR-Ts

CAR-Ts take centre stage again

Click here

Newsletter sign up

Sign up for the pharmaphorum daily newsletter.

Click here

First-line lung cancer: Merck & Co dominates with Keytruda

Click here

Clinical development strategies for checkpoint inhibitors (DRG)

Click here

Digital technology: Helping patients manage cancer, and enabling early diagnosis

Click here

Future editions

Click here

Transforming cancer care with blockchain technology (Witty Health)

Click here

Oncolytic viruses on the rise

Click here

Newsletter sign up

Sign up for the pharmaphorum daily newsletter.

Click here

The oncolytic virus renaissance: improving the efficacy of current immunotherapies (Oncolytics)

Click here

Prostate cancer: Maximising approved drugs’ potential and first signal immunotherapy work

Click here

Innovation in value assessment framework (Leela Barham)

Click here

Reassessing chemotherapy’s place in breast cancer treatment

Click here

Perfecting personalised medicine in cancer research (EORTC)

Click here

Proud to fight against cancer
Proud to fight against cancer

Click here

pharmaphorum connect customer engagement

pharmaphorum connect

Click here

Contact us

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

Google+

LinkedIn

Contact

Your name

Your e-mail

Your message

Send